Compton W M, Cottler L B, Ben Abdallah A, Phelps D L, Spitznagel E L, Horton J C
Department of Psychiatry, Washington University School of Medicine, St. Louis, Mo., USA.
Am J Addict. 2000 Spring;9(2):113-25. doi: 10.1080/10550490050173181.
Persons in drug treatment with drug dependence were interviewed with the NIMH Diagnostic Interview Schedule to ascertain DSM-III-R disorders. Lifetime prevalence rates were 64% for alcohol dependence, 44% for antisocial personality disorder (ASPD), 39% for phobic disorders, 24% for major depression, 12% for dysthymia, 10% for generalized anxiety disorder, 3% for panic disorder, 3% for mania, 3% for obsessive compulsive disorder, 2% for bulimia, 1% for schizophrenia, and 1% for anorexia. When stratified by race and age, significant main effects were seen, but there were no significant interactions except in "any non-substance disorder" and in the mean number of non-substance use disorders. Caucasians had a higher mean number of drug dependence disorders and higher overall rates of "any other" disorder than African-Americans, and Caucasians and males had higher mean numbers of non-substance use disorders than African-Americans and females, respectively. This was related to rates of alcohol, cannabis, and hallucinogen dependence, and ASPD rates that were higher among men than women and higher among Caucasian respondents than African-American for alcohol, cannabis, hallucinogen, opiate and sedative dependence, major depression, dysthymia, and generalized anxiety disorder. In contrast, women had higher rates than men of amphetamine dependence, phobic disorder, major depression, dysthymia, panic disorder, obsessive compulsive disorder, and mania. African-Americans had higher rates than Caucasians of amphetamine, cocaine, and phencyclidine dependence, but for no comorbid disorders were the rates higher among African-Americans than Caucasians. The differences according to gender in rates of disorders among substance dependent persons are consistent with the results of general population surveys, but the differences in rates according to race are in contrast to these same community surveys. Limitations in the utility of the concept of race as a valid category diminish the generalizability of the findings; however, one possible explanation is differential treatment seeking in African-American and Caucasian populations that would result in the differences seen.
使用《美国国立精神卫生研究所诊断访谈表》对有药物依赖的戒毒者进行访谈,以确定其是否患有《精神疾病诊断与统计手册》第三版修订版(DSM-III-R)中的疾病。终生患病率如下:酒精依赖为64%,反社会人格障碍(ASPD)为44%,恐惧症为39%,重度抑郁症为24%,心境恶劣为12%,广泛性焦虑障碍为10%,惊恐障碍为3%,躁狂症为3%,强迫症为3%,贪食症为2%,精神分裂症为1%,厌食症为1%。按种族和年龄分层时,可观察到显著的主效应,但除“任何非物质使用障碍”和非物质使用障碍的平均数量外,无显著交互作用。与非裔美国人相比,白人的药物依赖障碍平均数量更多,“任何其他”障碍的总体患病率更高;与非裔美国人和女性相比,白人和男性的非物质使用障碍平均数量分别更高。这与酒精、大麻和致幻剂依赖率以及ASPD率有关,在酒精、大麻、致幻剂、阿片类药物和镇静剂依赖、重度抑郁症、心境恶劣和广泛性焦虑障碍方面,男性高于女性,白人受访者高于非裔美国人。相比之下,女性在苯丙胺依赖、恐惧症、重度抑郁症、心境恶劣、惊恐障碍、强迫症和躁狂症方面的患病率高于男性。非裔美国人在苯丙胺、可卡因和苯环己哌啶依赖方面的患病率高于白人,但在任何共病障碍方面,非裔美国人的患病率均不高于白人。物质依赖者中疾病患病率的性别差异与一般人群调查结果一致,但种族患病率差异与这些社区调查结果相反。将种族概念作为一个有效类别使用时存在局限性,这降低了研究结果的普遍性;然而,一种可能的解释是,非裔美国人和白人在寻求治疗方面存在差异,从而导致了所观察到的差异。